Beyaz

Beyaz Therapeutics is an early-stage biotechnology company focused on the intersection of nutrition, metabolism, and epigenetics to develop novel therapeutic strategies. Founded on research from the Cold Spring Harbor Laboratory and the Koch Institute at MIT, the company investigates how dietary factors and metabolic states influence the epigenetic landscape of stem cells and immune cells. Their primary goal is to identify metabolic vulnerabilities in cancer and other diseases to enhance the efficacy of existing treatments like immunotherapy. By leveraging insights into how specific nutrients regulate gene expression, Beyaz Therapeutics aims to create a new class of precision medicines and dietary interventions.